Literature DB >> 17097754

Transient depletion of Ku70 and Xrcc4 by RNAi as a means to manipulate the non-homologous end-joining pathway.

Luciana R Bertolini1, Marcelo Bertolini, Gary B Anderson, Elizabeth A Maga, Knut R Madden, James D Murray.   

Abstract

Non-homologous end joining (NHEJ) is the major DNA double-strand break (DSB) repair pathway in mammalian cells and is likely responsible for the non-homologous integration of transgenes. In higher eukaryotes, this pathway predominates over the homologous recombination (HR) pathway and therefore may account for the low level of HR events that occur in mammalian cells. We evaluated the effects of transient RNAi-induced down-regulation of key components of the NHEJ pathway in human HCT116 cells. Treatment with siRNA targeting Ku70 and Xrcc4 reduced corresponding protein levels by 80-90% 48h after transfection, with a return to normal levels by 96h. Additionally, down-regulation of Ku70 and Xrcc4 resulted in a concomitant depletion of both Ku70 and Ku86 proteins. Biological consequences of transient RNAi-mediated depletion of Ku70 and Xrcc4 included sensitization to gamma radiation and a significant decrease in the expression of a linear GFP reporter gene. The results highlight the possibility of a successful means to manipulate the NHEJ pathway by RNAi.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097754     DOI: 10.1016/j.jbiotec.2006.10.003

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  11 in total

1.  Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population.

Authors:  Youle Su; Songtao Qi; Changwu Dou; Lian Shuang; Haicheng Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Chemoproteomic profiling identifies changes in DNA-PK as markers of early dengue virus infection.

Authors:  Michael L Vetter; Mary A Rodgers; Matthew P Patricelli; Priscilla L Yang
Journal:  ACS Chem Biol       Date:  2012-10-02       Impact factor: 5.100

3.  Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.

Authors:  Ming Yin; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Michael O'Reilly; Daniel Gomez; Minghuan Li; Ritsuko Komaki; Qingyi Wei
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

4.  Inhibition of FASN expression enhances radiosensitivity in human non-small cell lung cancer.

Authors:  Ning Zhan; Bin Li; Xiangying Xu; Jianyu Xu; Songliu Hu
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

Review 5.  Nanomedicine: tiny particles and machines give huge gains.

Authors:  Sheng Tong; Eli J Fine; Yanni Lin; Thomas J Cradick; Gang Bao
Journal:  Ann Biomed Eng       Date:  2013-12-03       Impact factor: 3.934

6.  Increased gene targeting in Ku70 and Xrcc4 transiently deficient human somatic cells.

Authors:  Luciana R Bertolini; Marcelo Bertolini; Elizabeth A Maga; Knut R Madden; James D Murray
Journal:  Mol Biotechnol       Date:  2008-08-30       Impact factor: 2.695

7.  Chemical and biological approaches to improve the efficiency of homologous recombination in human cells mediated by artificial restriction DNA cutter.

Authors:  Hitoshi Katada; Toshimasa Harumoto; Narumi Shigi; Makoto Komiyama
Journal:  Nucleic Acids Res       Date:  2012-02-23       Impact factor: 16.971

8.  Associations of LIG4 and HSPB1 genetic polymorphisms with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.

Authors:  Feng Xu; Ji-Chang Han; Ya-Jun Zhang; Yi-Jie Zhang; Xiao-Chun Liu; Guan-Bin Qi; Dan Liu; Yan-Zhi Chen; Yu-Xia Zhao; Lu Bai
Journal:  Biomed Res Int       Date:  2015-02-25       Impact factor: 3.411

9.  Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.

Authors:  Yuqing Wen; Gongpeng Dai; Liping Wang; Kanda Fu; Shuguang Zuo
Journal:  Biosci Rep       Date:  2019-03-19       Impact factor: 3.840

10.  Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.

Authors:  Grégory Nolens; Jean-Christophe Pignon; Benjamin Koopmansch; Benaïssa Elmoualij; Willy Zorzi; Edwin De Pauw; Rosita Winkler
Journal:  Breast Cancer Res       Date:  2009-11-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.